FDA issued a Warning Letter to Sal Pharma on 4/20/2017 as a result of this inspection.
FDA investigators audited the Sal Pharma - Hyderabad, India facility and issued inspectional observations (via FDA 483) on 01 Jul 2016.
Product details
- Category: Human Drugs
- Inspection end: 01 Jul 2016
- Location: Hyderabad, India
- FEI: 3003916387
